Ribavirin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Ribavirin.
| Product ID | 65841-260_061eb9f8-611d-449e-97f3-ccc9614ca18e |
| NDC | 65841-260 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ribavirin |
| Generic Name | Ribavirin |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2006-01-25 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077224 |
| Labeler Name | Cadila Healthcare Limited |
| Substance Name | RIBAVIRIN |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2006-01-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA077224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA077224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA077224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA077224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA077224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA077224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA077224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA077224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-01-25 |
| Ingredient | Strength |
|---|---|
| RIBAVIRIN | 200 mg/1 |
| SPL SET ID: | b97cd49c-9e19-4a35-987c-06e62bb25b6b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0781-2043 | Ribavirin | Ribavirin |
| 0781-5177 | Ribavirin | Ribavirin |
| 42494-423 | Ribavirin | Ribavirin |
| 53808-0781 | Ribavirin | RIBAVIRIN |
| 53808-0782 | Ribavirin | RIBAVIRIN |
| 54738-950 | ribavirin | ribavirin |
| 54738-951 | ribavirin | ribavirin |
| 54738-952 | ribavirin | ribavirin |
| 54738-953 | ribavirin | ribavirin |
| 63629-2149 | Ribavirin | Ribavirin |
| 65841-046 | Ribavirin | Ribavirin |
| 65841-129 | Ribavirin | Ribavirin |
| 65841-260 | Ribavirin | Ribavirin |
| 65841-603 | Ribavirin | Ribavirin |
| 65841-632 | Ribavirin | Ribavirin |
| 65862-207 | Ribavirin | Ribavirin |
| 68084-179 | Ribavirin | Ribavirin |
| 68382-046 | Ribavirin | Ribavirin |
| 68382-260 | Ribavirin | Ribavirin |
| 68382-129 | Ribavirin | Ribavirin |
| 68382-128 | Ribavirin | Ribavirin |
| 68382-395 | RIBAVIRIN | RIBAVIRIN |
| 68382-127 | Ribavirin | Ribavirin |
| 68682-019 | Ribavirin | Ribavirin |
| 65862-290 | Ribavirin | Ribavirin |
| 68475-003 | RIBAVIRIN | RIBAVIRIN |
| 0074-3197 | Moderiba | Ribavirin |
| 0074-3282 | Moderiba | Ribavirin |
| 0085-1318 | REBETOL | ribavirin |
| 0187-0007 | Virazole | Ribavirin |